236 related articles for article (PubMed ID: 16461407)
1. Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition.
Leidy C; Linderoth L; Andresen TL; Mouritsen OG; Jørgensen K; Peters GH
Biophys J; 2006 May; 90(9):3165-75. PubMed ID: 16461407
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.
Baker SF; Othman R; Wilton DC
Biochemistry; 1998 Sep; 37(38):13203-11. PubMed ID: 9748327
[TBL] [Abstract][Full Text] [Related]
3. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.
Tatulian SA
Biophys J; 2001 Feb; 80(2):789-800. PubMed ID: 11159446
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific Binding Domains in Lipid Membranes Induced by Phospholipase A2.
Hong CY; Han CT; Chao L
Langmuir; 2016 Jul; 32(27):6991-9. PubMed ID: 27218880
[TBL] [Abstract][Full Text] [Related]
5. Lipid ozonation products activate phospholipases A2, C, and D.
Kafoury RM; Pryor WA; Squadrito GL; Salgo MG; Zou X; Friedman M
Toxicol Appl Pharmacol; 1998 Jun; 150(2):338-49. PubMed ID: 9653065
[TBL] [Abstract][Full Text] [Related]
6. Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2.
Beers SA; Buckland AG; Giles N; Gelb MH; Wilton DC
Biochemistry; 2003 Jun; 42(24):7326-38. PubMed ID: 12809488
[TBL] [Abstract][Full Text] [Related]
7. A two-photon view of an enzyme at work: Crotalus atrox venom PLA2 interaction with single-lipid and mixed-lipid giant unilamellar vesicles.
Sanchez SA; Bagatolli LA; Gratton E; Hazlett TL
Biophys J; 2002 Apr; 82(4):2232-43. PubMed ID: 11916878
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.
Weinrauch Y; Abad C; Liang NS; Lowry SF; Weiss J
J Clin Invest; 1998 Aug; 102(3):633-8. PubMed ID: 9691100
[TBL] [Abstract][Full Text] [Related]
9. Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.
Koduri RS; Baker SF; Snitko Y; Han SK; Cho W; Wilton DC; Gelb MH
J Biol Chem; 1998 Nov; 273(48):32142-53. PubMed ID: 9822691
[TBL] [Abstract][Full Text] [Related]
10. Effects of lipid phase transition and membrane surface charge on the interfacial activation of phospholipase A2.
Ray S; Scott JL; Tatulian SA
Biochemistry; 2007 Nov; 46(45):13089-100. PubMed ID: 17944488
[TBL] [Abstract][Full Text] [Related]
11. Induction of the activation-related antigen CD69 on human eosinophils by type IIA phospholipase A2.
Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
Inflamm Res; 2000 Apr; 49(4):177-83. PubMed ID: 10858018
[TBL] [Abstract][Full Text] [Related]
12. Activation of phospholipase A2 in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine liposomes containing lipid ozonation products.
Salgo MG; Squadrito GL; Pryor WA
Chem Res Toxicol; 1994; 7(3):458-62. PubMed ID: 8075380
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase A2 and cobra venom cytotoxin Vc5 interactions and membrane structure.
Gasanov SE; Gasanov NE; Rael ED
Gen Physiol Biophys; 1995 Apr; 14(2):107-23. PubMed ID: 8846880
[TBL] [Abstract][Full Text] [Related]
16. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.
Adibhatla RM; Hatcher JF
Brain Res; 2007 Feb; 1134(1):199-205. PubMed ID: 17204250
[TBL] [Abstract][Full Text] [Related]
17. Synergism between mellitin and phospholipase A2 from bee venom: apparent activation by intervesicle exchange of phospholipids.
Cajal Y; Jain MK
Biochemistry; 1997 Apr; 36(13):3882-93. PubMed ID: 9092818
[TBL] [Abstract][Full Text] [Related]
18. The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity.
Salman M; Rottem S
Biochim Biophys Acta; 1995 May; 1235(2):369-77. PubMed ID: 7756347
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro.
Huhtinen HT; Grönroos JO; Grönroos JM; Uksila J; Gelb MH; Nevalainen TJ; Laine VJ
APMIS; 2006 Feb; 114(2):127-30. PubMed ID: 16519749
[TBL] [Abstract][Full Text] [Related]
20. Characterization and immunological comparison of isoenzymes of phospholipases A2 from snake venoms of different genera and families.
Chiou SH; Chuang LY; Chang CC
Biochem Int; 1991 Dec; 25(6):1003-11. PubMed ID: 1810246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
